HealthMerck to Boost Immunology Portfolio with $10.8 Billion Acquisition of Biotech Firm Pharmaceutical company Merck & Co has acquired biotech firm Prometheus Biosciences for $10.8 billion to strengthen its presence in the immunology field.by John Lopez
HealthRevolutionary GlucoScreen: Smartphone-Based System for Early Detection of Prediabetesby Jace Dela Cruz